Intermediate Capital Group logo

Intermediate Capital Group

Europe, England, United Kingdom, London

Description

Intermediate Capital Group (ICG) is a prominent global alternative asset manager headquartered in London, United Kingdom. Established in 1989, ICG has grown to become a specialist in private debt, credit, and equity investments, serving a diverse base of institutional clients worldwide. As of March 31, 2024, the firm boasts substantial assets under management (AUM) totaling approximately $92.7 billion (€85.2 billion), underscoring its significant footprint in the private capital markets. ICG's investment philosophy centers on providing flexible capital solutions across the capital structure, partnering with management teams to drive long-term value creation.

ICG's investment strategies are broadly categorized into private debt, credit, and private equity. Within private debt, they offer solutions such as direct lending, mezzanine financing, and senior debt to support leveraged buyouts, recapitalizations, and growth initiatives for established companies. Their credit platform encompasses corporate and structured credit strategies, providing financing across various industries. The private equity arm is particularly active in mid-market buyouts, growth equity, infrastructure equity, and real estate equity, targeting businesses with strong fundamentals and growth potential. This multi-asset approach allows ICG to deploy capital across different risk-return profiles and market cycles.

The firm typically targets established companies, ranging from mid-market enterprises to larger corporations, seeking to provide significant capital injections. For its private equity strategies, particularly within European and North American mid-market buyouts, ICG often makes equity investments ranging from approximately $54 million to $325 million (€50 million to €300 million) per transaction. While their private debt investments can sometimes involve smaller tranches, their typical first cheque reflects a substantial commitment to support meaningful growth or acquisition strategies.

ICG's extensive experience and broad investment capabilities position it as a key partner for companies seeking flexible capital solutions and for institutional investors looking for exposure to private markets. Their global presence, with offices across Europe, North America, and Asia, enables them to source and execute complex transactions on an international scale. The firm's disciplined investment approach and focus on value creation have contributed to its sustained growth and reputation as a leading alternative asset manager.

Investor Profile

Intermediate Capital Group has backed more than 30 startups, with 3 new investments in the last 12 months alone. The firm has led 21 rounds, about 70% of its total and boasts 9 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Series B, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United Kingdom, United States, France.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
  • Led 2 rounds in the past year.
  • Typical check size: $20M – $300M.

Stage Focus

  • Private Equity (57%)
  • Series B (10%)
  • Series Unknown (10%)
  • Debt Financing (7%)
  • Series A (7%)
  • Series C (3%)
  • Secondary Market (3%)
  • Series H (3%)

Country Focus

  • United Kingdom (30%)
  • United States (20%)
  • France (10%)
  • Norway (7%)
  • South Korea (7%)
  • The Netherlands (3%)
  • Finland (3%)
  • Denmark (3%)
  • India (3%)
  • Switzerland (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Information Technology
  • Therapeutics
  • Software
  • Medical
  • Wellness
  • Transportation
  • Food Processing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Intermediate Capital Group frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Access Biotechnology
North America, New York, United States, New York
Co-Investments: 3
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 2
3i Group
Europe, England, United Kingdom, London
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
Advent International
North America, Massachusetts, United States, Boston
Co-Investments: 1
Alpha Wave Global
North America, Florida, United States, Miami
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

Which angels does Intermediate Capital Group often collaborate with?

EF
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Intermediate Capital Group?

Draig Therapeutics

Cardiff, New South Wales, Australia

Draig Therapeutics is a clinical-stage biopharmaceutical startup.

BiotechnologyTherapeutics
Series AJun 18, 2025
Amount Raised: $140,000,000
Konecta

Córdoba, Cordoba, Argentina

Konecta specializes in the design of machines and industrial automation solutions.

Business Information SystemsOutsourcing
Private EquityFeb 12, 2025
Amount Raised: $77,699,273
F2G

Manchester, Manchester, United Kingdom

F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series HSep 12, 2024
Amount Raised: $100,000,000
Granlund

Helsinki, Southern Finland, Finland

Granlund specializes in design, consultancy and software services. The core of our expertise is energy efficiency.

ConstructionSoftware
Private EquityJun 19, 2024
Grey Wolf Therapeutics

Abingdon, Oxfordshire, United Kingdom

First-of-its-kind antigen modulation to address immune dysfunction in oncology and autoimmunity

BiotechnologyHealth CareTherapeutics
Series BMay 23, 2024
Amount Raised: $50,000,000
Astek Group

Boulogne-billancourt, Ile-de-France, France

Astek Group is an independent group specializing in engineering, technology, consulting and information systems.

Information ServicesInformation Technology
Private EquityApr 25, 2024
Amount Raised: $117,994,227
Staysure Group

Northampton, Northamptonshire, United Kingdom

Staysure Group is a travel insurance provider.

Auto InsuranceFinanceInsurance
Private EquityApr 8, 2024
Salboy

Warrington, Warrington, United Kingdom

Salboy is a property development company.

CommercialProperty DevelopmentReal EstateResidential
Debt FinancingMar 26, 2024
Amount Raised: $126,279,687
Enfinity

Miami, Florida, United States

Enfinity Global is a renewable energy company that focuses on developing, financing, and operating solar energy and energy storage projects.

EnergyRenewable EnergySolar
Private EquitySep 6, 2023
Amount Raised: $428,955,344
Direct Ferries

London, England, United Kingdom

Direct Ferries helps customers plan ferry routes and compare prices on different lines.

Service IndustryTicketingTransportation
Private EquityJun 14, 2023